https://pages.htgaa.org/2026b/leopold-heimer/week-01-hw-project-ideas/index.htmlhttps://drive.google.com/file/d/1bYcl7GqcwBosofRkfOj3yAfC6PKXy3e0/view?usp=drive_link My concept for a project is simple: a universal cure for bacterial infections. I’ve set out to achieve this via a combination of two molecules, Alpha-Methylglucoside (A-MG) and Egg White Lysozyme (EWL). The A-MG is present to slow/halt bacterial replication. [1] EWL is an enzyme that kills bacteria. This one-two punch system uses two molecules that are very difficult to evolve resistance to. A-MG is a non-metabolizable glucose analog, and EWL induces lysis. Now, let’s talk about economics. Naturally, I don’t know the exact dosage quantities of costs involved, so I will have to make some estimations. Firstly, I will be assuming that the dose size is equal to that of nafcillin. This isn’t ideal (and is certainly not correct [hopefully a highball estimate]), but it will suffice for now. This quantity is 500 mg every 4-6 hours (2,400 mg per day). The cost of retrieving recombinant EipB from liquid-cultured E. coli was 52.5$/g. [4] This means that a single adult daily dosage costs roughly 126$. Of course, a liquid-culturing robot could be used to improve the efficiency of the system. Citations:Hugoen